unitaid approach to working in markets to improve public health
DESCRIPTION
Presentation with the occasion of the Technical Briefing at World Halth Assembly, Geneva, 18 May 2011TRANSCRIPT
- 1. UNITAID approach to working in markets to improve public health Technical Briefing World Health Assembly, Geneva 18 May, 2011 Brenda Waning
- 2. Session Agenda
- Brief overview of UNITAID: why and how UNITAID works through markets to improve public health
- Key highlights of UNITAIDs portfolio to date: proof of concept that market approaches work
- New opportunities for market interventions to improve health
- Trends in organizations moving to adopt market approaches: presentations from other stakeholders
- 3. UNITAID: a WHO Partnership moving markets Partners Working
towards the common goal of expanding access to health
- Est. 2006: Innovative finance mechanism based largely on air tax levies from north & south
- Geneva-based
- secretariat: no in-country offices work with partners
- First and only UN organization to work exclusively through markets to improve public health
-
- HIV/AIDS, TB, malaria
- 4. UNITAID Goal Healthy markets, healthy people UNITAID aims to promote healthy, dynamic market conditions whereby manufacturers have incentives to invest and innovate , while at the same time supply quality public health products at affordable prices and in acceptable formulations that enable the maximum number of people to access them.
- 5. What is a market?
- 6. Market impact framework UNITAID Intervention example: 2 nd line ARV market
- 7. How UNITAID intervenes
-
- UNITAIDs role depends upon the particular circumstances in a given market:
- Market catalyst: identifying and facilitating adoption and uptake of new and/or superior public health products;
- Market creator: providing incentives for manufacturers to produce otherwise unattractive products with low demand that yield little profit but substantial public health benefit to those in need; and
- Market fixer: addressing severe market inefficiencies (e.g. grossly inaccurate demand forecasts and excessive transaction costs) that contribute to low access to quality-assured public health products.
-
- 8. UNITAID examples (a few)
- Market catalyst:
- Second-line ARV (& tenofovir) programs
- Expand TB (diagnostic line probe assay)
- Market creator:
- Paediatric programs for HIV/AIDS & TB
- Affordable Medicines Facility for Malaria (AMFm)
- Market "fixer":
-
-
- WHO Prequalification of Medicines Programme
-
-
-
- Medicines patent pool
-
-
-
- Strategic rotating stockpile for TB medicines
-
-
-
- ACT Forecasting
-
-
-
- Market intelligence systems
-
- 9. Market intelligence: the GPS of market interventions Used to locate "global positions" around interventions before & after implementation UNITAID accounts for > 90% market for paediatric ARVs in fixed-dose combination form, 2009* 90% pediatric & adult 1 st line ARVs made by Indian generic producers, 2008 *
- 10. New opportunities: the Decade of Diagnostics
- Unprecedented innovation in diagnostics technology
-
- Better chemistry, simpler to use, more affordable
-
- Finally will be able to bring diagnostics to people and regions previously underserved
- Xpert MTB
-
- Dramatic breakthrough in lab-based tuberculosis diagnostic technology
- Malaria Rapid Diagnostic Tests
-
- From labs (microscopes) to homes (disposable Point of Care tests)
- HIV CD4 and Viral Load
-
- From central labs to clinics (Point of Care tests)
- 11. CD4 Product Pipeline*
- 12. Viral Load & EID Product Pipeline*
- 13. UNITAID is one of several players working to keep markets
in balance to improve public health
-
- UNITAID showed proof of concept: market interventions have substantial, long term impact far beyond country recipients
-
- Many others now adopting market approaches: coordination & collaboration to leverage relative strengths & maximize use of resources towards achieving collective public health goals
-
- 14.
- Thank you
- Contact Information:
- Brenda Waning
- Coordinator, Market Dynamics
- WHO/UNITAID
- Email: [email_address]